Free Republic
Browse · Search
General/Chat
Topics · Post Article

To: Steve Van Doorn; numberonepal

Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection.

An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in the first of usually three phases of clinical testing, the University of Oxford said in a statement on Tuesday.

Also, the immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.

https://news.yahoo.com/astrazenecas-covid-vaccine-suffers-setback-230741535.html

I guess Xlear is better! Lol.


1,909 posted on 10/11/2022 10:24:18 AM PDT by Melian ( Unity is all. )
[ Post Reply | Private Reply | To 1846 | View Replies ]


To: Melian

FAIL!


1,952 posted on 10/11/2022 12:15:13 PM PDT by numberonepal (WWG1WGA)
[ Post Reply | Private Reply | To 1909 | View Replies ]

Free Republic
Browse · Search
General/Chat
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson